Clinical Trial Update: Efficacy of Clopidogrel on Incidence of Silent Brain Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing whether clopidogrel reduces the incidence of silent brain infarctions; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Silent Brain Infarction

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Silent Brain Infarction | Phase 4 | Status: ACTIVE_NOT_RECRUITING